[ Price : $8.95]
Neopharm Inc. says a pivotal Phase 3 trial involving an experimental cancer drug failed to meet its efficacy endpoint.[ Price : $8.95]
FDA sets a user fee action date of 4/26/07 for Sanofi-Aventis NDA resubmission on weight-loss drug Acomplia.[ Price : $8.95]
FDA and Baxter warn healthcare professionals about the possibility of delayed onset of heparin-induced thrombocytopenia.[ Price : $8.95]
Federal Register Final rule: FDA approves an IVX Animal Health supplemental ANADA to revise labeling of generic oxytetracycline to...[ Price : $8.95]
The U.S. Attorney in San Francisco subpoenas marketing and medical education documents from Gilead Sciences for three HIV drugs.[ Price : $8.95]
As incoming House Government Reform chairman Henry Waxman takes note, Sen. Chuck Grassley lambastes FDA secrecy and alleged intimi...[ Price : $8.95]
FDA approves a Millennium Pharmaceuticals supplemental NDA for Velcades use in treating relapsed mantle cell lymphoma.[ Price : $8.95]
Federal Register Final rule: FDA approves an Agri Laboratories ANADA that provides for oral use of lyncomycin and spectinomycin to...